<DOC>
	<DOCNO>NCT02066974</DOCNO>
	<brief_summary>Hepatocellular carcinoma ( HCC ) common cause cancer mortality Asia . Most patient present advanced disease . Percutaneous ethanol injection , radiofrequency ablation , transcatheter arterial chemoembolization ( TACE ) consider curative treatment achieve limited success eradicate large HCC tumor cause portal vein thrombosis . With development novel radiotherapy ( RT ) technique , RT safely give patient large tumor portal vein thrombosis . However , RT could achieve tumor response rate approximately 50 % . Currently , paucity study regard quantitative biomarker predict tumor response forecast outcome advance . To optimize therapeutic index , need seek effective biomarkers personal medicine pretreatment AFP always useful surrogate marker patient . The present study investigate whether circulate tumor cell genome peripheral blood use predict RT response HCC . We use blood sample patient locally advance HCC receive RT . By use next generation sequencing , We go explore quantity quality change DNAs RNAs patient 's serum plasma . By way , genomic expression peripheral blood may play key role determine optimal therapeutic strategy HCC patient predict tumor response RT .</brief_summary>
	<brief_title>Circulating Tumor Cell Genome Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy</brief_title>
	<detailed_description>Patients hepatocellular carcinoma require radiotherapy</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Patients unresectable hepatoma transarterial chemoembolization ( TACE ) failure suitable TACE . A maximal tumor diameter &gt; 3.0 cm Age &gt; 20 , &lt; 80 year ECOG 0 1 Life expectancy least 12 week ChildPugh A Cancer Liver Italian Program ( CLIP ) score ≦ 3 Pretreatment liver function test renal function test : Total bilirubin &lt; 1.5 time upper limit normal ( ULN ) , GOP/GPT ≦ 5 X upper limit normal range , Alkaline phosphatase ≦ 4X ULN , Prothrombin time / partial prothrombin time &lt; 1.5 X ULN , Serum Creatinine ≦ 1.0 x ULN Pretreatment blood count : Hemoglobulin ≧ 9 g/dl , Absolute neutrophil count ≧ 1500/mm3 , Platelet count ≧ 100,000/mm3 Subjects least one unidimensional bidimensional measurable lesion lesion must measure CT scan ChildPugh C CLIP score ≧ 4 Patients evidence extrahepatic metastatic disease Patients evidence massive ascites Patients receive previous irradiation liver</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>genomic expression</keyword>
	<keyword>radiotherapy</keyword>
</DOC>